Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BLISSGVS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
Moderate ROE but improving trend
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Moderate operating margin but declining trend
Low revenue growth and in line with median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
BLISSGVS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BLISSGVS Bulk, Block & Insider Trades
BLISSGVS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Bonus(3 new shares for 5 existing shares)Bonus Issue of 3 shares for every 5 shares held. AGM Date: 12th Sep 2008. Ex-date: 26th Sep 2008 Announced on: 29th Jul 2008
Bonus(2 new shares for 5 existing shares)Bonus issue of 1040000 securities Ex-date: 28th Sep 2005 Announced on: 2nd Aug 2005
Stock split(1 : 10)Nominal value change from Rs. 10 to Rs. 1 each. Ex-date: 11th Mar 2008 Announced on: 19th Jan 2008
Company Profile
Bliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointmen... Read More
Key personnel
Mr. Narsimha Shibroor Kamath
Chief Executive Officer, Managing Director
Mr. Deepak Sawant
Chief Financial Officer
Ms. Aditi Himanshu Bhatt
Compliance Officer, Company Secretary
Ms. Shruti Vishal RaoD
Whole-Time Director
Ms. Vibha Gagan SharmaD
Whole-Time Director
Ms. Shilpa BhatiaD
Independent Woman Director
Mr. Santosh Laxman ParabD
Independent Director
Dr. Nandkumar Kashinath ChodankarD
Additional Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Bliss GVS Pharma Ltd.?
The current share price of Bliss GVS Pharma Ltd. is ₹ 175.25 as of 09 Jan 2026.
What is the PE ratio of Bliss GVS Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Bliss GVS Pharma Ltd. is 16.91 as of the latest financial data.
What is the ROE and ROCE of Bliss GVS Pharma Ltd.?
Bliss GVS Pharma Ltd. has a Return on Equity (ROE) of 10.23% and a Return on Capital Employed (ROCE) of 8.52% as per the latest financial reports.
What is the market cap of Bliss GVS Pharma Ltd.?
The market capitalization of Bliss GVS Pharma Ltd. stands at ₹ 1,853.95 Cr.
What is the dividend yield of Bliss GVS Pharma Ltd.?
The dividend yield of Bliss GVS Pharma Ltd. is 0.29% based on the current market price.
What is the RSI of Bliss GVS Pharma Ltd.?
The Relative Strength Index (RSI) of Bliss GVS Pharma Ltd. is 56.25.
What is the FII and DII holding in Bliss GVS Pharma Ltd.?
Foreign Institutional Investors (FII) hold 13.27% and Domestic Institutional Investors (DII) hold 5.98% of Bliss GVS Pharma Ltd. shares.
What sector does Bliss GVS Pharma Ltd. belong to?
Bliss GVS Pharma Ltd. operates in the Healthcare sector.
What is the beta of Bliss GVS Pharma Ltd. stock?
The beta of Bliss GVS Pharma Ltd. stock is 1.11, indicating its volatility relative to the broader market.
